Y-Intercept (HK)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Y-Intercept (HK)’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.05M	Buy	120,824 +49,366	+69%	+$789K	0.04%	689
2026 Q1	$1.06M	Buy	+71,458	New	+$1.04M	0.02%	1011
2025 Q2	–	Sell	-17,410	Closed	-$140K	–	1624
2025 Q1	$140K	Buy	+17,410	New	+$141K	0.01%	1090
2023 Q2	–	Sell	-10,586	Closed	-$116K	–	1258
2023 Q1	$116K	Sell	10,586 -6,210	-37%	-$54.7K	0.01%	1039
2022 Q4	$72.6K	Buy	+16,796	New	+$97.5K	0.01%	906

Other funds holding AUPH

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Acropolis Investment Management St. Louis, Missouri $2.25B AUM 17.77% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return